Posts

Posted on

Hydrogen’s Role in Clean Energy to Take the Spotlight in SoCalGas’ “H2 Hydrogen Home”

First project of its kind in the U.S. aims to show how this carbon-free gas made from renewable electricity can fuel clean energy systems in a carbon-neutral future

PR Newswire

LOS ANGELES, Dec. 15, 2020 /PRNewswire/ — As part of its efforts to support California’s climate change goals and its mission to become the cleanest, safest and most innovative energy company in America, Southern California Gas Co. (SoCalGas) today announced it will build a state-of-the-art demonstration project to show the role hydrogen could play in attaining California’s goal of achieving carbon neutrality. Named the H2 Hydrogen Home, the project is the first of its kind in the U.S. and will include a home, solar panels, a home battery, an electrolyzer to convert solar energy into clean hydrogen, and a fuel cell to convert that hydrogen back to electricity. The hydrogen will also be blended with natural gas for use in the home’s appliances. The H2 Hydrogen Home is expected to be complete by late 2021. An ad promoting the demonstration home is available via this link.

“California will continue to lead by bringing green hydrogen into its energy mix, just as it led by integrating renewable electricity and batteries for electric storage,” said Maryam Brown, SoCalGas president. “The H2 Hydrogen Home will help guide decision-making that will ultimately create the 21st century energy system needed to provide clean, affordable and resilient energy for Californians.”

“As we move to a clean energy future, hydrogen is a zero-emission fuel that could play a significant role in California,” said California Assemblymember Jacqui Irwin. “This demonstration home will be a great way to see hydrogen in action. Looking forward I am excited about the development of hydrogen technology as a way to create jobs for Californians in a green economy.”

“This home is a great way to show in a tangible way how green hydrogen can store renewable power for an unlimited length of time and how it can be reconverted to electricity whenever it’s needed,” said Janice Lin, Founder and President of the Green Hydrogen Coalition.

The H2 Hydrogen Home is designed with solar panels, which will power the project’s home on sunny days and also provide excess electricity that will be stored for night use and cloudy days. Some of that extra electricity will charge a home battery for short-term energy storage. The rest of the solar power will be converted to clean hydrogen using an electrolyzer and stored until needed. That stored hydrogen will also be converted back to electricity with an on-site fuel cell.  And finally, the hydrogen will be blended with natural gas and used in the home’s heat pump HVAC unit, water heater, clothes dryer, and gas stove.

Hydrogen provides an ideal solution for long-term storage of renewable energy on the larger grid as well, according to energy experts. While power from solar and wind can be stored for several hours in grid-scale batteries, there are times when longer-term storage is needed. Converting renewable electricity to hydrogen allows it to be stored for weeks, months or years. The hydrogen can then be converted back to clean electricity and dispatched to the power grid when it is needed to supplement solar and wind generation or battery storage, using either turbine generators, or fuel cells. Such a system is also far more cost-effective than one that uses batteries only, according to a recent study by Caltech.

SoCalGas is collaborating with ATCO and leveraging the design and experience gained in the process of developing its Clean Energy Innovation Hub (CEIH) in Perth, Australia. ATCO designed and constructed the CEIH in 2019, funded in part by Australia’s Renewable Energy Agency. The CEIH serves as a living lab to test hybrid energy solutions, and integrates solar panels, battery storage, natural gas and hydrogen production.

The H2 Hydrogen Home project is part of SoCalGas’ work to support a 21st energy system that provides clean, affordable, and resilient energy for Californians. The company’s mission is to build the cleanest, safest and most innovative energy company in North America.

About SoCalGas

Headquartered in Los Angeles, SoCalGas® is the largest gas distribution utility in the United States. SoCalGas delivers affordable, reliable, clean and increasingly renewable gas service to 21.8 million customers across 24,000 square miles of Central and Southern California, where more than 90% of residents use natural gas for heating, hot water, cooking, drying clothes or other uses. Gas delivered through the company’s pipelines also plays a key role in providing electricity to Californians— about 45% of electric power generated in the state comes from gas-fired power plants.

SoCalGas’ mission is to build the cleanest, safest and most innovative energy company in America, delivering affordable and increasingly renewable energy to its customers. In support of that mission, SoCalGas is committed to replacing 20% of its traditional natural gas supply with renewable natural gas (RNG) by 2030. Renewable natural gas is made from waste created by dairy farms, landfills and wastewater treatment plants. SoCalGas is also committed to investing in its gas delivery infrastructure while keeping bills affordable for our customers. From 2015 through 2019, the company invested nearly $7 billion to upgrade and modernize its pipeline system to enhance safety and reliability. SoCalGas is a subsidiary of Sempra Energy (NYSE: SRE), an energy services holding company based in San Diego. For more information visit socalgas.com/newsroom or connect with SoCalGas on Twitter(@SoCalGas), Instagram(@SoCalGas) and Facebook.  

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hydrogens-role-in-clean-energy-to-take-the-spotlight-in-socalgas-h2-hydrogen-home-301193178.html

SOURCE Southern California Gas Company

Posted on

Serco Joins Forces with Davie on its Polar Icebreaker Program

OTTAWA, ONTARIO, CANADA, Dec. 15, 2020 (GLOBE NEWSWIRE) — Serco Canada Marine (Serco) a Canadian leader in integrated, complex ship design is proud to announce its partnership with Davie Shipyard on its Polar Icebreaker program, the flagship of Davie’s National Icebreaker Centre. As a design and engineering partner, Serco will provide the Davie team with engineering, project management and production support. 

With decades of experience in managing large-scale procurement and production programs for military and civilian vessels, advanced logistics, and sustainment support projects, Serco has supported the development of the Royal Canadian Navy’s Joint Support Ship (JSS), the Halifax Class Patrol Frigates, the first fully electric green ferries in Ontario, and the Canadian Coast Guard’s Offshore Fisheries Science Vessels, among other high-profile vessels.

Globally, Serco is recognized for its full lifecycle approach to maritime assets. It has a proven track record of delivering large, complex ship designs spanning naval, coast guard, research and civilian ships. Serco has extensive icebreaker experience, including leadership of the design and build of Australia’s flagship research and supply ship, the RSV Nuyina – global experience that will be leveraged as part of Serco’s engagement with Davie.  Serco will now operate and maintain the RSV Nuyina for the Australian Antarctic Division for the next 20 years.

Launched last August, Davie’s National Icebreaking Centre is a growing centre of excellence for Polar and Arctic expertise. Its focus is on building Canadian capability that supports the rejuvenation of Canada’s ice-capable fleet. These efforts will create thousands of high-quality jobs, drive domestic economic growth and future exports of Canadian innovation. Furthermore, it will enable Canada to create a high value export sector for world-class ships for the Arctic. Specifically, building icebreakers with Davie will create a unique capability in Canada that can be leveraged on the international stage.

“Serco is committed to developing Canada’s shipbuilding industry both inside and outside the Defence market. Our Canadian footprint continues to grow as we expand our design and engineering capability and build our in-service-support offering to better serve our customers. Strategic partnerships like the one we’ve entered into with Davie Shipbuilding, allow us the opportunity to further expand our in-country offering, and better position the company for domestic and international pursuits,” said Russell Peters, General Manager of Serco Canada Marine.

“Serco is a natural partner for Canada’s National Icebreaker Centre – builder of the new Polar class, and the entire Canadian icebreaker fleet. We will immediately leverage Serco’s unsurpassed icebreaker experience both in Canada and worldwide, having recently delivered one of the world’s most advanced polar icebreakers to Australia. Having worked with Serco on other strategic projects, we know they will provide unrivalled engineering, project management and production support to our Polar program, ensuring this game-changing ship enters service to protect Canada’s Arctic interests without delay.” James Davies, President and CEO, Davie Shipbuilding.

About Serco:  Serco Canada Marine is a leader in naval architecture, specifically engineering for the design, construction and maintenance of marine vessels and structures, notably surface ships and submarines. The company has decades of experience in managing large-scale procurement and production programs for military and civilian vessels, advanced logistics, and sustainment support projects. Serco’s team has supported the development of the Royal Canadian Navy’s Joint Support Ship (JSS), the Halifax Class Patrol Frigates, the first fully electric green ferries in Ontario, and the Canadian Coast Guard’s Offshore Fisheries Science Vessels, among other high-profile vessels. Serco Canada employs more than 1,200 people across the country. Its parent company, Serco Inc. is a leading provider of professional, technology, and management services, and has approximately 8,500 employees across North America and annual revenue of $1.2 billion. Serco Inc. is a wholly-owned subsidiary of Serco Group plc, a global company with more than 50,000 employees, who operates internationally across four geographies: UK & Europe, North America, Asia Pacific and the Middle East. 

About Davie Shipbuilding: Based in Lévis, Québec, Davie is Canada’s premier shipbuilder and a global leader in the delivery of specialist, mission-critical vessels to government and commercial customers. Founded in 1825, Davie is Canada’s longest established, largest and highest capacity shipbuilder. Our world-class workforce builds and sustains complex ships that enable our customers to protect national and economic security, or fulfill acute business needs. Find out more at www.davie.ca and www.icebreakercentre.ca 

### 



Alan Hill
Serco Inc
703-263-6500
[email protected]

Posted on

RENOWN INSTITUTE FOR HEALTH INNOVATION EXPANDS PARTNERSHIP WITH GILEAD SCIENCES AND SIEMENS HEALTHINEERS TO OFFER ELF- ENHANCED LIVER FIBROSIS TESTING FOR NEVADA NASH STUDY PARTICIPANTS

Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses

RENO, Nev., Dec. 15, 2020 (GLOBE NEWSWIRE) — Renown Institute for Health Innovation (IHI)  announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP).

 

The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition.

 

Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD.

 

“Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”

 

“Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”

 

“We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers.

 

“We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.”

 

The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases.  

 

###

 

About NAFLD and NASH

NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver.  Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1).  The symptoms of NASH are often silent or non-specific, making it difficult to diagnose.  About one-third of people with NASH develop cirrhosis or irreversible liver damage (2).

 

About the ELF™ Test

The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis.

 

The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact [email protected] or (775) 982-6914. 

 

The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.

 

In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only.

 

About Renown Health

Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org.

 

About the Renown Institute for Health Innovation

Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

 

Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org.

 

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.



Renown Health Public Relations
Renown Health
775-691-7308
[email protected]

Lance Longwell
Siemens Healthineers
610-448-6341
[email protected]

Posted on

Red Cat Holdings Announces Trading to Commence on the OTCQB Venture Market December 15, 2020

PR Newswire

SAN JUAN, Puerto Rico, Dec. 15, 2020 /PRNewswire/ — Red Cat Holdings, Inc., (OTCQB:RCAT) today announced it will commence trading on the OTCQB venture market with the market open on Tuesday, December 15, 2020.  The Company will continue to trade under the symbol “RCAT”.

The Company provides products, services and solutions to the drone industry. We design, develop, market, and sell drone products under our Fat Shark, Red Cat and Rotor Riot brands. We sell First Person View (FPV) video goggles for pilots to fly drones and for gaming, and have the largest market share of drone goggle sales. We also provide software design and are developing systems to perform flight data analytics, storage and diagnostics.  Our services also include drone media, training and sales through our dedicated ecommerce store.

The OTCQB Venture Market is limited to companies that are committed to providing investors with high-quality trading and improved market visibility. OTCQB equities are traded through OTC Link®, an inter-dealer quotation and trading messaging system developed by OTC Markets Group. Subscribing broker-dealers can view and publish quotes and negotiate trades through its SEC-registered Alternative Trading System.

“We are pleased to have Red Cat Holdings on the OTCQB Venture Market, a key milestone that enables a larger investor audience to participate in the fast-growing drone industry,” said Jeff Thompson, founder and Chief Executive Officer of Red Cat.

The move to the OTCQB will not impact or require additional action from shareholders. The stock continues to trade on OTC but now will now be accessible to investors and traders through the middler OTC Markets tier.

To learn more about Red Cat Holdings, please visit www.redcatholdings.com, www.redcat.red and www.rotorriot.com.

Safe Harbor

The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “anticipates,” “plans,” “expects,” “intends,” “will,” “potential,” “hope” and similar expressions are intended to identify forward-looking statements.  These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company’s periodic filings with the Securities and Exchange Commission, including the factors described in the sections entitled “Risk Factors”, copies of which may be obtained from the SEC’s website at www.sec.gov. The parties do not undertake any obligation to update forward-looking statements contained in this press release.

Contact
Chad Kapper
Phone: ‪(818) 906-4701
E-mail: [email protected] 
Website: https://rotorriot.com 

Investor Relations Contact
Bruce Haase
RedChip Companies
(407) 712-8965
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/red-cat-holdings-announces-trading-to-commence-on-the-otcqb-venture-market-december-15-2020-301193173.html

SOURCE Red Cat Holdings, Inc.

Posted on

Insight Named a Strong Performer in First Computer Vision Consultancies Report by Top Independent Research

Insight Named a Strong Performer in First Computer Vision Consultancies Report by Top Independent Research

Insight has the expertise in building CV pipelines that fit hardware constraints and the IoT platforms to manage them, according to the Forrester report

TEMPE, Ariz.–(BUSINESS WIRE)–
Insight Enterprises (NASDAQ: NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, has been named a strong performer in the report, The Forrester New Wave™: Computer Vision Consultancies, Q4 2020. Forrester evaluated 13 of the top computer vision (CV) providers across 10 criteriato help application development and delivery professionals, line-of-business and IT executives select the right partner for their CV needs.

Insight was recognized for its deployment of innovative CV solutions at the edge. According to the report, “Insight has the expertise in building CV pipelines that fit the hardware constraints and the Internet of Things (IoT) platforms to manage them.”

“IoT, connected devices and data are exploding and rapidly changing the world around us, from enabling autonomous vehicles, to detecting and preventing the spread of viruses, to helping manage remote field operations with greater efficiency and precision,” said Ken Lamneck, Insight president and CEO. “We know organizations need flexible, scalable solutions to make better sense and holistic use of their data through IoT and machine-learning applications. We’ve brought to market several smart solutions that take advantage of the power of computers to ‘see’ and translate information into practical business applications.”

Insight worked with one of North America’s largest railroad companies on an IoT-powered drone solution to remotely monitor track conditions and automate preventative maintenance based on digital images. A similar, automated “Drone as a Service” model was developed for a major Midwest utility company to safely inspect wind turbines from a distance by analyzing drone imaging of turbine blades.

Insight also partnered with a global mining company to employ a camera and sensor-driven artificial intelligence (AI) system to optimize performance of crushed ore bins and enhance the safety of workers who no longer need to manually inspect the equipment.

With a team of 1,200 Digital Innovation engineers, architects and technical consultants, Insight maintains the expertise to design and manage CV models deployed across mobile devices, vehicles, and in settings with limited or no network connectivity.

Its Insight Connected Platform™, a flexible, scalable IoT application for managing people, places, equipment and notifications, has accelerated Insight’s ability to deliver innovative CV solutions to clients across industries and across the world. The proprietary platform is core to its ability to deliver solutions at the edge, collecting data from IoT-connected devices and sensors to provide real-time data visualization that informs decision-making.

“We know how to transform data into intelligence through edge computing, and the Insight Connected Platform helps our clients innovate, realize efficiencies and improve operations,” said Stan Lequin, senior vice president and general manager, Digital Innovation at Insight. “When we drive business outcomes through digital innovation and the intelligent use of data for our clients, we are a true, trusted partner helping lead them on a digital transformation journey.”

To download a complimentary copy of the Forrester New Wave™: Computer Vision Consultancies Report, visit insight.com here. For more information on Insight’s Digital Innovation solutions, contact Insight at [email protected] or 800-INSIGHT.

About Insight

Today, every business is a technology business. Insight Enterprises Inc. empowers organizations of all sizes with Insight Intelligent Technology Solutions™ and services to maximize the business value of IT. As a Fortune 500-ranked global provider of Digital Innovation, Cloud + Data Center Transformation, Connected Workforce, and Supply Chain Optimization solutions and services, we help clients successfully manage their IT today while transforming for tomorrow. From IT strategy and design to implementation and management, our 11,000 teammates help clients innovate and optimize their operations to run business smarter. Discover more at www.insight.com. NSIT-M

Scott Walters

Insight Enterprises

Tel. (480) 889-9798

Email: [email protected]

Ariel Kouvaras

Sloane & Company

Tel. (212) 446-1884

Email: [email protected]

KEYWORDS: United States North America Arizona

INDUSTRY KEYWORDS: Data Management Technology Other Technology Software Internet Hardware

MEDIA:

Posted on

Biloxi Marsh Lands Corporation Announces Unaudited Results for the Third Quarter and First Nine Months of 2020

Biloxi Marsh Lands Corporation Announces Unaudited Results for the Third Quarter and First Nine Months of 2020

METAIRIE, La.–(BUSINESS WIRE)–
Biloxi Marsh Lands Corporation (PINK SHEETS: BLMC) today announces its unaudited results for the third quarter of 2020 and first nine months of 2020. The Company’s revenue for the three months ended September 30, 2020 from oil and gas production for its fee lands was $1,557 compared to revenue of $7,165 for the third quarter of 2019. Dividend and interest income for the third quarter of 2020 was $11,233 compared to $22,596 for 2019. The Company realized a cumulative gain from the sale of investment securities of $31,519 compared to a cumulative gain of $64,736 for the same period of 2019. The flow-through losses from the Company’s membership interests in limited liability companies was $73,188 for the third quarter of 2020 compared to $488,652 for 2019. During the third quarter of 2020, the Company recognized a settlement gain in the amount of $1,607,716. Expenses for the third quarter were $102,321 compared to $178,577 for the same period of 2019. The Company had net income of $1,546,908 or $0.62 per share for the third quarter of 2020 compared to a net loss of $483,946 or $0.19 per share in 2019. For the first nine months of 2020, there was net income of $521,134 or $0.21 per share compared to a net loss of $1,836,698 or $0.73 per share for the same period of 2019.

Due to office closures caused by COVID-19 and various tropical weather events, the timeliness of the Company’s office administration has been hindered slightly, but its field operations continue with impact only from the tropical weather events.

The Company’s claim (Biloxi Marsh Lands Corp., et al. v. United States; Case No. 12-382L) in the U.S. Court of Federal Claims against the U.S. Army Corps of Engineers seeking monetary damages for property damage and losses caused by the Mississippi River Gulf Outlet is in the process of moving forward. The U.S. Department of Justice filed a motion for summary judgment on the issue of statute of limitations concerning the portion for the Company’s claim related to a taking of real property. The parties continue to await the Court’s decision. The Company cannot predict the timing of resolution or the outcome of this litigation process, but it is anticipated that this litigation process will take time.

During the third quarter, the Company received a settlement payment for its wetlands real property claim under the Halliburton Energy Service, Inc. / Transocean Settlements arising out of the Deepwater Horizon incident in the Gulf of Mexico beginning on April 20, 2010. These settlements are separate from the BP Deepwater Horizon Economic and Property Damages Settlement Program. The Company has been advised by our legal counsel that no additional recovery under the settlements is expected related to the BP Deepwater Horizon oil spill.

B&L Exploration, LLC (“BLX”), of which the Company owns a 75% membership interest, is contractually entitled to a 1.5% of 8/8ths overriding royalty interest (ORRI) in the mineral leases comprising the 9,000 acre – EOC-TUSC BL UDS SUA production unit from which the Highlander well is producing. This production unit is located in St. Martin Parish, Louisiana. A series of public hearings have taken place with respect to the production unit. The public meeting to consider the application by one of mineral owners requesting that the size of the unit be reduced was held and an order by the Louisiana’s Department of Natural Resources (“LDNR”), Office of Conservation has yet to be posted on LDNR’s website. Information reported by the Highlander well’s operator to LDNR is available on LDNR’s Strategic Online Natural Resources Information System (SONRIS – www.sonris.com).

BLX continues its operations in South Texas. As previously reported, B&L Resources, LLC (“BLR”), of which the Company owns a 50% membership interest, continues its development efforts in South Texas and is focused on its recent acquisition of Heyser Field from Frostwood Energy, LLC.

Biloxi Marsh Lands Corporation is a Delaware corporation whose principal assets are surface and mineral rights to approximately 90,000 acres of marsh land in St. Bernard Parish, Louisiana, which from time to time generates revenues from mineral activities including lease bonuses, delay rentals, royalties on oil and natural gas production, and fee land income unrelated to oil and gas activities. Through investment in limited liability companies the Company also has separate interests in various oil and gas properties in Louisiana and Texas outside of its fee lands.

We encourage you to visit our website to obtain general information about the Company, its efforts in the coastal restoration arena, as well as historical annual reports and press releases. We strongly recommend that all interested parties become familiar with the information available on the Company’s website: www.biloximarshlandscorp.com.

This news release contains forward-looking statements regarding all of the Company’s business activities including without limitation oil and gas discoveries, oil and gas exploration, and development and production activities and reserves. Accuracy of the forward-looking statements depends on assumptions about events that change over time and is thus susceptible to periodic change based on actual experience and new developments. The Company cautions readers that it assumes no obligation to update or publicly release any revisions to the forward-looking statements in this report. Important factors that might cause future results to differ from these forward-looking statements include: variations in the market prices of oil and natural gas; drilling results; unanticipated fluctuations in flow rates of producing wells; oil and natural gas reserves expectations; the ability to satisfy future cash obligations and environmental costs; and general exploration and development risks and hazards. Readers are cautioned not to place undue reliance on forward-looking statements made by or on behalf of the Company. Each such statement speaks only as of the day it was made. The factors described above cannot be controlled by the Company. When used in this report, the words “believes”, “estimates”, “plans”, “expects”, “could”, “should”, “outlook”, and “anticipates” and similar expressions as they relate to the Company or its management are intended to identify forward-looking statements.

The following “Statements of Assets, Liabilities and Stockholders’ Equity” and “Statements of Revenues and Expenses”have been derived from interim unaudited financial statements which do not include the information and footnotes that are an integral part of a complete financial statement.

Inquiries should be made through the Contact Mailbox on the Company’s website: http://www.biloximarshlandscorp.com/contact/.

BILOXI MARSH LANDS CORPORATION
Statements of Assets, Liabilities, and Stockholders’ Equity
September 30, 2020 and 2019
 
Assets

2020

2019
 
Current assets:
Cash and cash equivalents $

2,280,913

916,830

Accounts receivable

33,071

7,501

Prepaid expenses

49,402

68,840

Deferred tax asset

—

21,159

Income taxes receivable

4,882

28,817

Other assets

3,830

3,830

Total current assets

2,372,098

1,046,977

Other assets:
Membership interest in limited liability companies

312,241

311,962

Marketable debt and equity securities – at cost

3,799,001

5,386,720

Land

234,939

234,939

Total other assets

4,346,181

5,933,621

 
Total assets $

6,718,279

6,980,598

Liabilities and Stockholders’ Equity
Current liabilities:
Accrued expenses $

34,115

57,169

Membership interest in limited liability companies

684,294

—

Total current liabilities

718,409

57,169

Stockholders’ equity:
Common stock, $.001 par value. Authorized, 20,000,000 shares;
issued, 2,851,196 shares; outstanding, 2,505,028 shares

47,520

47,520

Retained earnings

9,029,375

9,952,934

Treasury stock – 346,168 shares, at cost

(3,077,025)

(3,077,025)

Total liabilities and stockholders’ equity $

6,718,279

6,980,598

BILOXI MARSH LANDS CORPORATION
Statements of Revenues and Expenses
September 30, 2020 and 2019
 

3 Months Ended

 

9 Months Ended

September 30

 

September 30

2020

 

2019

 

2020

 

2019
 
Revenues:
Oil and gas royalties

$ 1,557

7,165

$ 6,512

$ 11,619

Total oil and gas revenues

1,557

7,165

6,512

11,619

 
Other income (loss):
Dividends and interest income

11,233

22,596

43,041

81,451

Gain (loss) on sale of securities

31,519

64,736

(81,196)

(172,766)

Gain on settlement

1,607,716

–

1,761,510

–

Fee land income

70,392

88,786

70,392

142,422

Loss from membership interest in limited liability companies

(73,188)

(488,652)

(884,709)

(1,336,693)

Total other income

1,647,672

(312,534)

909,038

(1,285,586)

Total revenues and other income

1,649,229

(305,369)

915,550

(1,273,967)

 
Expenses:
Total expenses

102,321

178,577

394,416

562,731

Net income before income taxes

1,546,908

(483,946)

521,134

(1,836,698)

Income tax expense (benefit)

–

–

–

–

Net income

$ 1,546,908

(483,946)

$ 521,134

(1,836,698)

 
Net income per share

$ 0.62

$ (0.19)

$ 0.21

$ (0.73)

 

Biloxi Marsh Lands Corporation

Belle Bellard: 504-837-4337

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Energy Other Energy Oil/Gas

MEDIA:

Posted on

doTERRA Receives Top Workplaces and Best of State Awards

PLEASANT GROVE, UTAH, Dec. 15, 2020 (GLOBE NEWSWIRE) — doTERRA has been recognized as a top workplace in Utah by The Salt Lake Tribune and recently received two Best of State Awards. The company employs more than 4,300 people worldwide, with over 3,000 employees based at the corporate headquarters in Pleasant Grove, Utah. Through doTERRA’s unique essential oil sourcing model, the company also directly supports over 300,000 additional jobs, which impacts many more lives.

“We are grateful that our employees love working at doTERRA,” said Mark Wolfert, founding executive. “We care about every aspect of our employees’ lives, from their financial success to their mental and physical wellbeing, and provide a number of unique benefits, including matching 401K, childcare, service opportunities, and an on-site medical clinic. The culture of doTERRA is one of empowerment and respect, and we are always looking for talent that will appreciate and enhance our atmosphere and contribute to the company’s larger mission.”

Find doTERRA employment opportunities here.

In addition to being recognized as a top workplace in the State of Utah for 2020, doTERRA was recognized by Best of State as the 2020 Winner in the Essential Oils/Botanicals category for the sixth consecutive year and the 2020 Winner in Corporate Giving. These awards highlight doTERRA’s mission to empower through purity: pure products, pure business practices, pure intentions, and the pure love of humanity.

“We are honored to be recognized once again alongside so many exceptional companies for these prestigious awards,” said Emily Wright, doTERRA founding executive. “We work hard to create a winning culture and deliver the highest quality products in the industry with a commitment to do good wherever we live and work. The focus on giving back is inherent in our DNA as we are changing the world one drop, one person, one community at a time.” 

About Top Workplaces

The Top Workplaces list is based solely on employee feedback gathered through a third-party survey administered by Energage, LLC. The anonymous survey uniquely measures 15 drivers of engaged cultures that are critical to the success of any organization: including alignment, execution, and connection, just to name a few.

About Best of State

The Best of State Awards were created to recognize the people, organizations, and businesses that are achieving, innovating, and improving the quality of life in Utah. Judges review submitted material and online nominations, and assign three separate scores to each nominee, for a total of 100 possible points. Fifty percent of the points are for overall achievement and excellence in service, products, or performance. Another thirty percent is for innovation, creativity, and differentiation. The remaining twenty percent is for contributions that make Utah a better place to live. Each company is measured against the Best of State Moto: “Excelling and Surpassing All Else.”

About doTERRA

dōTERRA® International is an integrative health and wellness company and the world leader in the Global Aromatherapy and Essential Oils market. dōTERRA sources, tests, manufactures and distributes CPTG Certified Pure Therapeutic Grade® essential oils and essential oil products to over eight million dōTERRA Wellness Advocates and customers. Through industry leading responsible sourcing practices, dōTERRA maintains the highest levels of quality, purity and sustainability in partnership with local growers around the world through Cō-Impact Sourcing®. The dōTERRA Healing Hands Foundation®, a registered 501(c)(3) non-profit organization, offers resources and tools to global sourcing communities and charitable organizations for self-reliance, healthcare, education, sanitation, and the fight against human trafficking. Through the life-enhancing benefits of essential oils, dōTERRA is changing the world one drop, one person, one community at a time. To learn more, visit www.doterra.com.

Attachment 



Kevin Wilson
doTERRA
[email protected]

Posted on

Life Extension Launches New Longevity Formula Bio-Fisetin

Promotes cellular senescence and longevity with fisetin enhanced formulation that offers higher absorption than fisetin alone

Fort Lauderdale, FL, Dec. 15, 2020 (GLOBE NEWSWIRE) — Fruits and vegetables are packed with fisetin, a type of plant compound that is known for promoting healthy cellular metabolism and senescence, thus promoting longevity. The problem? Fisetin rapidly becomes inactive during digestion. To help the body fully utilize fisetin’s many health benefits, Life Extension has launched Bio-Fisetin, a new supplement that uses a novel delivery technique which allows the plant nutrient to be absorbed in a way that conventional fisetin formulas simply can’t match.

“We’re excited about our fisetin formula,” said Dr. Michael Smith, Life Extension’s Director of Education. “We combined fisetin with special galactomannan compounds from fenugreek seeds to inhibit fisetin from becoming inactive. This delivery technique allows fisetin to stay in the body for a longer period, making it up to 25 times more available than unformulated fisetin. So, the body can access the health benefits it offers.”

The fenugreek fiber coating works by surrounding fisetin and shielding it from undergoing biotransformation, which is the process that renders it inactive, according to Dr. Smith.

Fisetin has long been studied by longevity experts, because it can actively target senescent or aging cells. These are cells that were once healthy but no longer function optimally, a process known as cellular senescence. Over time, aging cells can accumulate and affect the day-to-day function of the healthy cells around them. A study published in the online journal BioMedicine found that, after testing 10 different flavonoids, fisetin proved to have the highest senolytic activity. This means it can encourage the body’s natural clearing and recycling process, supporting cellular health and longevity.

Fisetin also regulates sirtuin function, another critical aspect of cellular longevity. Sirtuin proteins are responsible for maintaining cells performing at their best, but sirtuin activity declines with age. Emerging research shows that fisetin encourages youthful, healthy sirtuin function.

Fisetin also has antioxidant properties, which help support healthy brain function by inhibiting inflammatory factors and protecting delicate brain cells from oxidative stress.7 And by promoting healthy sugar metabolism and maintaining blood sugar levels within a normal range, fisetin protects eye and kidney health.

Life Extension’s once-daily, innovative botanical Bio-Fisentin formula is gluten free, vegetarian, and non-GMO.

About Life Extension®

For 40 years, Life Extension has pursued innovative advances in health, conducting rigorous clinical trials and setting some of the most demanding standards in the industry to offer a full range of quality vitamins and nutritional supplements and blood-testing services. Life Extension’s Wellness Specialists provide personalized counsel to help customers choose the right products for optimal health, nutrition and personal care. To learn more, visit LifeExtension.com.

These statements have not been evaluated by the Food and Drug Administration. 
This product is not intended to diagnose, treat, cure, or prevent any disease

 

Attachments 



Rey Searles
Life Extension
954-766-8433
[email protected]

Posted on

Stars Realign As Football Legend Neymar Jr Goes All In With Pokerstars

Global sports icon returns to the world’s largest online poker site

PR Newswire

TORONTO, Dec. 15, 2020 /PRNewswire/ — Brazilian football star Neymar Jr has today confirmed he is re-joining PokerStars for an exciting new partnership.

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8828951-neymar-jr-goes-all-in-with-pokerstars/.

The partnership is set to be a true collaboration seen across many aspects of the brand. With his off the field passion for poker and gaming, the global sporting icon is a perfect fit for PokerStars and will bring his flair and personality to the online and live tables, as well as to the PokerStars community across the world.

The announcement marks the start of Neymar Jr’s new chapter with PokerStars, the home of poker, casino, and sports. A new brand film teases what is to come as Neymar Jr declares he is ‘IN’ and invites all players into his inner circle, showing the Brazilian star is taking his role well and truly beyond just advertising.

Neymar Jr said, “When I’m not playing football, I love playing cards. Competing with my friends is a huge passion of mine, I love the sense of community, the fun, and the unpredictable moments that can occur in any game. As a true poker fan, I am excited to start a new chapter with PokerStars. Together we’ll be creating moments for our community and fans all over the world.”

The signing follows a recent global brand refresh for PokerStars as it looks to move beyond just product in a bid to become a global entertainment brand. The brand refresh included PokerStars first dedicated safer gambling TV ads which are just one part of our commitment to keep players safe. The PokerStars dedicated, award winning responsible gaming team was one of the first in the industry and is an integral part of the business.

Martin Nieri, Global Director of Brand and Creative at PokerStars, said: “Neymar Jr is a true global superstar. But what underpins this partnership is his genuine love for poker. It’s about a shared passion for the game and the beautiful uncertainty at the heart of it. At PokerStars, we are constantly trying new things to bring new energy, excitement, and entertainment to our customers. Together with Neymar Jr we believe we can take this to the next level for the PokerStars community.”

PokerStars x Neymar Jr are set to be the ultimate pair in poker. This is only the start of the journey with more to be revealed in 2021. Until then, a sneak-peak of what’s to come can be found here.

Play Responsibly! For more information on responsible gaming please visit our website at http://www.pokerstars.com/about/responsible-gaming/.

NOTES TO EDITORS:

About PokerStars

PokerStars operates the world’s most popular online poker sites, serving the global poker community. Since it launched in 2001, PokerStars has become the first choice of players all over the world, with more daily tournaments than anywhere else and with the best online security. More than 200 billion hands have been dealt on PokerStars, which is more than any other site.

PokerStars is ultimately owned by Flutter Entertainment plc. (LSE: FLTR) (EURONEXT: FLTR).

Play Responsibly! For more information on responsible gaming please visit our website at http://www.pokerstars.com/about/responsible-gaming/.

Photo – https://mma.prnewswire.com/media/1386233/PokerStars_Neymar_Jr.jpg
Logo – https://mma.prnewswire.com/media/1164298/PokerStars_Logo.jpg

 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/stars-realign-as-football-legend-neymar-jr-goes-all-in-with-pokerstars-301193163.html

SOURCE PokerStars

Posted on

ICPT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Intercept Pharmaceuticals Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) from September 28, 2019, through October 7, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Intercept securities, and/or would like to discuss your legal rights and options please visit Intercept Shareholder Lawsuit or contact Joseph R. Seidman Jr. toll free at (877) 779-1414 or [email protected].

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendants downplayed the true scope and severity of safety concerns associated with Ocaliva’s use in treating PBC; (ii) the foregoing increased the likelihood of an FDA investigation into Ocaliva’s development, thereby jeopardizing Ocaliva’s continued marketability and the sustainability of its sales; (iii) any purported benefits associated with OCA’s efficacy in treating NASH were outweighed by the risks of its use; (iv) as a result, the FDA was unlikely to approve the Company’s NDA for OCA in treating patients with liver fibrosis due to NASH; and (v) as a result of all the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

On May 22, 2020, Intercept reported that the FDA “has notified Intercept that its tentatively scheduled June 9, 2020 advisory committee meeting (AdCom) relating to the company’s [NDA] for [OCA] for the treatment of liver fibrosis due to [NASH] has been postponed” to “accommodate the review of additional data requested by the FDA that the company intends to submit within the next week.” On this news, Intercept’s stock price fell $11.18 per share, or 12.19%, to close at $80.51 per share on May 22, 2020.

On June 29, 2020, Intercept issued a press release announcing that the FDA had issued a Complete Response Letter (“CRL”) rejecting the Company’s NDA for Ocaliva for the treatment of liver fibrosis due to NASH. According to that press release, “[t]he CRL indicated that, based on the data the FDA has reviewed to date,” the FDA “has determined that the predicted benefit of OCA based on a surrogate histopathologic endpoint remains uncertain and does not sufficiently outweigh the potential risks to support accelerated approval for the treatment of patients with liver fibrosis due to NASH.” The press release further advised, among other things, that the “[t]he FDA recommends that Intercept submit additional post-interim analysis efficacy and safety data from the ongoing REGENERATE study in support of potential accelerated approval and that the long-term outcomes phase of the study should continue.” On this news, Intercept’s stock price fell $30.79 per share, or 39.73%, to close at $46.70 per share on June 29, 2020.

Then, on October 8, 2020, news outlets reported that Intercept was “facing an investigation from the [FDA] over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.” On this news, Intercept’s stock price fell $3.30 per share, or 8.05%, to close at $37.69 per share on October 8, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than January 4, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Intercept securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/interceptpharmaceuticalsinc-icpt-shareholder-class-action-lawsuit-stock-fraud-331/apply/ or contact Joseph R. Seidman Jr. toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Joseph R. Seidman, Jr.
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]